Targeted and global pharmacometabolomics in everolimus-based immunosuppression: association of co-medication and lysophosphatidylcholines with dose requirement

Overview of attention for article published in Metabolomics, November 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

So far, Dimensions has found 2 publications that cite this research output.

Article in Pharmaceuticals (November 2023)

Article in Drug Metabolism and Pharmacokinetics (December 2020)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.